Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Eccentric Resistance Training Strategy to Maximize Exercise Induced Muscle Damage in Young Adults

NCT06992271 is registered in ClinicalTrials.gov with New York Institute of Technology as lead sponsor.

NCT NCT06992271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06992271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Eccentric Resistance Training Strategy to Maximize Exercise Induced Muscle Damage in Young Adults
Lead sponsor
New York Institute of Technology
Phase
Not applicable
Overall status
Recruiting
Start date
March 8, 2023
Completion date
June 1, 2025
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eccentric hypertrophy, muscle damage